Being Patient

This #LiveTalk is today! We hope you can join us and let us know if you have any questions

🧠 Do you know the first “red flag” for #Alzheimers? A buildup of beta-amyloid — sometimes decades before symptoms show up. Our free interactive guide explores Alzheimer’s key protein biomarkers, how they’re measured, and why testing still requires full clinical evaluation. 🔗 Download it now: https://buff.ly/ADQO8tS

In this edition of The Brain Brief, Being Patient founder Deborah Kan shares her cheat sheet from the Alzheimer’s Association International Conference — including what’s next for blood-based biomarkers, monoclonal antibodies, and why Roche’s latest therapy is one to watch. 🔔 Subscribe to The Brain Brief, Being Patient’s LinkedIn newsletter for must-know insights on #brainhealth, #dementia, and the future of Alzheimer’s care.

🧠 At age 70, Gregory Nelson received an #Alzheimers #diagnosis after noticing word loss, confusion, and overwhelming feelings. “One day at a time, that is what has been really important for me…this is the day that we will have a good life.” 📢 Do you have a #JourneyToDiagnosis story to share? We’d love to hear it! Share in the comments or email lauren@beingpatient.com. #BPJourneyToDiagnosis #AlzheimersAwareness

💊 Experimental #Alzheimers #drug #trontinemab appeared to clear plaques fast with few serious side effects in early trials. Roche says a Phase 3 will launch as soon as this year. 🔗 Here's more: https://buff.ly/SdjxzyO #AAIC #AAIC25

🧠 An #MCI #diagnosis doesn’t always lead to #dementia — and #Alzheimers isn’t always the cause. 🔗 Neurologists say identifying and addressing underlying #health conditions can lead to better outcomes and, in some cases, total recovery. Read the full article: https://buff.ly/aTEhztq

Women are more likely to develop Alzheimer’s and other dementias. Can understanding sex differences in the brain help us understand these conditions better – and develop better treatments? Join us Friday, August 8 at 11 a.m. PT / 2 p.m. ET for a #LiveTalk with Dr. Fanny Elahi, associate professor of neurology at Mount Sinai. Her research uncovers how biological factors influence the development of cognitive impairment and dementia. Elahi leads a multidisciplinary lab focused on modeling disease and identifying early biomarkers and therapeutic targets. RSVP to learn more: https://lnkd.in/gV6Tucch

🧪 New Alzheimer’s #drugs like #Leqembi and #Kisunla offer promise — but did you know #ApoE4 carriers may face higher risks of side effects? Our interactive guide explores what it means for #diagnosis, treatment, and future planning. “So, if you are not an ApoE4 carrier, your risk of progression to dementia is six percent per year. If you’re an ApoE4 carrier, it’s 17 percent per year, so it is a significant predictor of future decline." -Dr Marwan Sabbagh, Barrow Neurological Institute 🔗 Learn more and explore the guide here: https://buff.ly/PvJ13x6 🔗

🏊 🚴 🏃 “Movement is medicine…I feel like I’m punching the disease in the face.” Diagnosed with #Alzheimers and mild cognitive impairment, Ironmen Dan Jaworski and Scott Berkheiser haven’t stopped competing — or inspiring. “Don’t give up. As long as you try your best, it’s all that matters.” Watch their powerful story in the full video from Being Patient's Mark Niu. 👇 📢 Do you have a #JourneyToDiagnosis story to share? We’d love to hear it! Share in the comments or email lauren@beingpatient.com. #BPJourneyToDiagnosis #AlzheimersAwareness #BrainHealth #MCI

🩸 From #bloodtests to new #drug trials, #AAIC25 showcased major advances in #Alzheimers diagnostics, treatments and prevention strategies. 🔗 Here are the highlights: https://buff.ly/XM6mWiH